IBDEI1XV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30965,1,4,0)
;;=4^M31.1
;;^UTILITY(U,$J,358.3,30965,2)
;;=^119061
;;^UTILITY(U,$J,358.3,30966,0)
;;=E85.81^^123^1598^7
;;^UTILITY(U,$J,358.3,30966,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30966,1,3,0)
;;=3^Light Chain (AL) Amyloidosis
;;^UTILITY(U,$J,358.3,30966,1,4,0)
;;=4^E85.81
;;^UTILITY(U,$J,358.3,30966,2)
;;=^5151302
;;^UTILITY(U,$J,358.3,30967,0)
;;=E85.82^^123^1598^23
;;^UTILITY(U,$J,358.3,30967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30967,1,3,0)
;;=3^Wild-Type Transthyretin-Related (ATTR) Amyloidosis
;;^UTILITY(U,$J,358.3,30967,1,4,0)
;;=4^E85.82
;;^UTILITY(U,$J,358.3,30967,2)
;;=^5151303
;;^UTILITY(U,$J,358.3,30968,0)
;;=E85.89^^123^1598^1
;;^UTILITY(U,$J,358.3,30968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30968,1,3,0)
;;=3^Amyloidosis,Other
;;^UTILITY(U,$J,358.3,30968,1,4,0)
;;=4^E85.89
;;^UTILITY(U,$J,358.3,30968,2)
;;=^334034
;;^UTILITY(U,$J,358.3,30969,0)
;;=Z87.442^^123^1599^1
;;^UTILITY(U,$J,358.3,30969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30969,1,3,0)
;;=3^Personal Hx of Urinary Calculi
;;^UTILITY(U,$J,358.3,30969,1,4,0)
;;=4^Z87.442
;;^UTILITY(U,$J,358.3,30969,2)
;;=^5063497
;;^UTILITY(U,$J,358.3,30970,0)
;;=N20.0^^123^1599^2
;;^UTILITY(U,$J,358.3,30970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30970,1,3,0)
;;=3^Calculus of Kidney
;;^UTILITY(U,$J,358.3,30970,1,4,0)
;;=4^N20.0
;;^UTILITY(U,$J,358.3,30970,2)
;;=^67056
;;^UTILITY(U,$J,358.3,30971,0)
;;=N20.1^^123^1599^3
;;^UTILITY(U,$J,358.3,30971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30971,1,3,0)
;;=3^Calculus of Ureter
;;^UTILITY(U,$J,358.3,30971,1,4,0)
;;=4^N20.1
;;^UTILITY(U,$J,358.3,30971,2)
;;=^5015608
;;^UTILITY(U,$J,358.3,30972,0)
;;=N20.2^^123^1599^4
;;^UTILITY(U,$J,358.3,30972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30972,1,3,0)
;;=3^Calculus of Kidney w/ Calculus of Ureter
;;^UTILITY(U,$J,358.3,30972,1,4,0)
;;=4^N20.2
;;^UTILITY(U,$J,358.3,30972,2)
;;=^5015609
;;^UTILITY(U,$J,358.3,30973,0)
;;=N20.9^^123^1599^5
;;^UTILITY(U,$J,358.3,30973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30973,1,3,0)
;;=3^Urinary Calculus,Unspec
;;^UTILITY(U,$J,358.3,30973,1,4,0)
;;=4^N20.9
;;^UTILITY(U,$J,358.3,30973,2)
;;=^5015610
;;^UTILITY(U,$J,358.3,30974,0)
;;=E72.53^^123^1599^6
;;^UTILITY(U,$J,358.3,30974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30974,1,3,0)
;;=3^Hyperoxaluria
;;^UTILITY(U,$J,358.3,30974,1,4,0)
;;=4^E72.53
;;^UTILITY(U,$J,358.3,30974,2)
;;=^60210
;;^UTILITY(U,$J,358.3,30975,0)
;;=R78.89^^123^1600^1
;;^UTILITY(U,$J,358.3,30975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30975,1,3,0)
;;=3^Lithium Toxicity
;;^UTILITY(U,$J,358.3,30975,1,4,0)
;;=4^R78.89
;;^UTILITY(U,$J,358.3,30975,2)
;;=^5019588
;;^UTILITY(U,$J,358.3,30976,0)
;;=Z99.2^^123^1601^3
;;^UTILITY(U,$J,358.3,30976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30976,1,3,0)
;;=3^Dependence on Renal Dialysis
;;^UTILITY(U,$J,358.3,30976,1,4,0)
;;=4^Z99.2
;;^UTILITY(U,$J,358.3,30976,2)
;;=^5063758
;;^UTILITY(U,$J,358.3,30977,0)
;;=Z91.15^^123^1601^6
;;^UTILITY(U,$J,358.3,30977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30977,1,3,0)
;;=3^Noncompliance w/ Renal Dialysis
;;^UTILITY(U,$J,358.3,30977,1,4,0)
;;=4^Z91.15
;;^UTILITY(U,$J,358.3,30977,2)
;;=^5063617
;;^UTILITY(U,$J,358.3,30978,0)
;;=Z49.31^^123^1601^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XV 3757 printed Sep 23, 2025@19:53:56 Page 2
IBDEI1XV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30965,1,4,0)
+2 ;;=4^M31.1
+3 ;;^UTILITY(U,$J,358.3,30965,2)
+4 ;;=^119061
+5 ;;^UTILITY(U,$J,358.3,30966,0)
+6 ;;=E85.81^^123^1598^7
+7 ;;^UTILITY(U,$J,358.3,30966,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,30966,1,3,0)
+10 ;;=3^Light Chain (AL) Amyloidosis
+11 ;;^UTILITY(U,$J,358.3,30966,1,4,0)
+12 ;;=4^E85.81
+13 ;;^UTILITY(U,$J,358.3,30966,2)
+14 ;;=^5151302
+15 ;;^UTILITY(U,$J,358.3,30967,0)
+16 ;;=E85.82^^123^1598^23
+17 ;;^UTILITY(U,$J,358.3,30967,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,30967,1,3,0)
+20 ;;=3^Wild-Type Transthyretin-Related (ATTR) Amyloidosis
+21 ;;^UTILITY(U,$J,358.3,30967,1,4,0)
+22 ;;=4^E85.82
+23 ;;^UTILITY(U,$J,358.3,30967,2)
+24 ;;=^5151303
+25 ;;^UTILITY(U,$J,358.3,30968,0)
+26 ;;=E85.89^^123^1598^1
+27 ;;^UTILITY(U,$J,358.3,30968,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,30968,1,3,0)
+30 ;;=3^Amyloidosis,Other
+31 ;;^UTILITY(U,$J,358.3,30968,1,4,0)
+32 ;;=4^E85.89
+33 ;;^UTILITY(U,$J,358.3,30968,2)
+34 ;;=^334034
+35 ;;^UTILITY(U,$J,358.3,30969,0)
+36 ;;=Z87.442^^123^1599^1
+37 ;;^UTILITY(U,$J,358.3,30969,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,30969,1,3,0)
+40 ;;=3^Personal Hx of Urinary Calculi
+41 ;;^UTILITY(U,$J,358.3,30969,1,4,0)
+42 ;;=4^Z87.442
+43 ;;^UTILITY(U,$J,358.3,30969,2)
+44 ;;=^5063497
+45 ;;^UTILITY(U,$J,358.3,30970,0)
+46 ;;=N20.0^^123^1599^2
+47 ;;^UTILITY(U,$J,358.3,30970,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,30970,1,3,0)
+50 ;;=3^Calculus of Kidney
+51 ;;^UTILITY(U,$J,358.3,30970,1,4,0)
+52 ;;=4^N20.0
+53 ;;^UTILITY(U,$J,358.3,30970,2)
+54 ;;=^67056
+55 ;;^UTILITY(U,$J,358.3,30971,0)
+56 ;;=N20.1^^123^1599^3
+57 ;;^UTILITY(U,$J,358.3,30971,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,30971,1,3,0)
+60 ;;=3^Calculus of Ureter
+61 ;;^UTILITY(U,$J,358.3,30971,1,4,0)
+62 ;;=4^N20.1
+63 ;;^UTILITY(U,$J,358.3,30971,2)
+64 ;;=^5015608
+65 ;;^UTILITY(U,$J,358.3,30972,0)
+66 ;;=N20.2^^123^1599^4
+67 ;;^UTILITY(U,$J,358.3,30972,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,30972,1,3,0)
+70 ;;=3^Calculus of Kidney w/ Calculus of Ureter
+71 ;;^UTILITY(U,$J,358.3,30972,1,4,0)
+72 ;;=4^N20.2
+73 ;;^UTILITY(U,$J,358.3,30972,2)
+74 ;;=^5015609
+75 ;;^UTILITY(U,$J,358.3,30973,0)
+76 ;;=N20.9^^123^1599^5
+77 ;;^UTILITY(U,$J,358.3,30973,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,30973,1,3,0)
+80 ;;=3^Urinary Calculus,Unspec
+81 ;;^UTILITY(U,$J,358.3,30973,1,4,0)
+82 ;;=4^N20.9
+83 ;;^UTILITY(U,$J,358.3,30973,2)
+84 ;;=^5015610
+85 ;;^UTILITY(U,$J,358.3,30974,0)
+86 ;;=E72.53^^123^1599^6
+87 ;;^UTILITY(U,$J,358.3,30974,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,30974,1,3,0)
+90 ;;=3^Hyperoxaluria
+91 ;;^UTILITY(U,$J,358.3,30974,1,4,0)
+92 ;;=4^E72.53
+93 ;;^UTILITY(U,$J,358.3,30974,2)
+94 ;;=^60210
+95 ;;^UTILITY(U,$J,358.3,30975,0)
+96 ;;=R78.89^^123^1600^1
+97 ;;^UTILITY(U,$J,358.3,30975,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,30975,1,3,0)
+100 ;;=3^Lithium Toxicity
+101 ;;^UTILITY(U,$J,358.3,30975,1,4,0)
+102 ;;=4^R78.89
+103 ;;^UTILITY(U,$J,358.3,30975,2)
+104 ;;=^5019588
+105 ;;^UTILITY(U,$J,358.3,30976,0)
+106 ;;=Z99.2^^123^1601^3
+107 ;;^UTILITY(U,$J,358.3,30976,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,30976,1,3,0)
+110 ;;=3^Dependence on Renal Dialysis
+111 ;;^UTILITY(U,$J,358.3,30976,1,4,0)
+112 ;;=4^Z99.2
+113 ;;^UTILITY(U,$J,358.3,30976,2)
+114 ;;=^5063758
+115 ;;^UTILITY(U,$J,358.3,30977,0)
+116 ;;=Z91.15^^123^1601^6
+117 ;;^UTILITY(U,$J,358.3,30977,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,30977,1,3,0)
+120 ;;=3^Noncompliance w/ Renal Dialysis
+121 ;;^UTILITY(U,$J,358.3,30977,1,4,0)
+122 ;;=4^Z91.15
+123 ;;^UTILITY(U,$J,358.3,30977,2)
+124 ;;=^5063617
+125 ;;^UTILITY(U,$J,358.3,30978,0)
+126 ;;=Z49.31^^123^1601^1
